Ming-Ying Xie (Mingyin Xie, Mingying Xie)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 8

Top Topics

Peritoneal Dialysis

Small Cell Lung Cancer

Prognostic Factors

Top Venues

Cell death & disease

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Zi-Chao Zhou, Kai-Yan Chen, Na Li, Ming-Ying Xie, Jia-Min Sheng, Yun Fan, Zhi-Yu Huang
Real-world utilization of PD-1/PD-L1 inhibitors with palliative radiotherapy in patients with metastatic non-small cell lung cancer. Thoracic cancer 13 (16) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Na Li, Ming-Ying Xie, Zi-Chao Zhou, Jia-Min Sheng, Xiaoqing Yu, Yun Fan
Real-world treatment and prognostic factors for survival in ALK+ non-small cell lung cancer (NSCLC) patients with brain metastases in China. Thoracic cancer (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Jia-Min Sheng, Hui Li, Xiaoqing Yu, Sizhe Yu, Kai-Yan Chen, Guoqiang Pan, Ming-Ying Xie, Na Li, Zi-Chao Zhou, Yun Fan
Efficacy of PD-1/PD-L1 inhibitors in patients with non-small cell lung cancer and brain metastases: A real-world retrospective study in China. Thoracic cancer 12 (22) (2021)